Search Results - "Préat, Veronique"

Refine Results
  1. 1

    Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes by Thwala, Lungile Nomcebo, Préat, Veronique, Csaba, Noémi Stefania

    Published in Expert opinion on drug delivery (02-01-2017)
    “…Protein and peptide-based drugs are preferred therapeutics due to their specificity but are mainly administered by injection. Alternative routes for peptide…”
    Get more information
    Journal Article
  2. 2

    Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models by Bastiancich, Chiara, Lemaire, Laurent, Bianco, John, Franconi, Florence, Danhier, Fabienne, Préat, Veronique, Bastiat, Guillaume, Lagarce, Frederic

    Published in Nanomedicine (London, England) (01-08-2018)
    “…Anticancer drug-loaded hydrogels are a promising strategy for the local treatment of incurable brain tumors such as glioblastoma (GBM). Recently, we…”
    Get full text
    Journal Article
  3. 3

    Antimicrobial peptide-gold nanoscale therapeutic formulation with high skin regenerative potential by Comune, Michela, Rai, Akhilesh, Chereddy, Kiran K., Pinto, Sandra, Aday, Sezin, Ferreira, André F., Zonari, Alessandra, Blersch, Josephine, Cunha, Rodrigo, Rodrigues, Ricardo, Lerma, Juan, Simões, Pedro N., Préat, Veronique, Ferreira, Lino

    Published in Journal of controlled release (28-09-2017)
    “…Chronic skin wounds affect ≈3% of persons aged >60years (Davies et al., 2007) [1]. These wounds are typically difficult to heal by conventional therapies and…”
    Get full text
    Journal Article
  4. 4

    In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma by Estella-Hermoso de Mendoza, Ander, Préat, Veronique, Mollinedo, Faustino, Blanco-Prieto, María J.

    Published in Journal of controlled release (20-12-2011)
    “…Edelfosine is the prototype molecule of a family of anticancer drugs collectively known as synthetic alkyl-lysophospholipids. This drug holds promise as a…”
    Get full text
    Journal Article
  5. 5

    To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery by Danhier, Fabienne, Feron, Olivier, Préat, Véronique

    Published in Journal of controlled release (01-12-2010)
    “…Because of the particular characteristics of the tumor microenvironment and tumor angiogenesis, it is possible to design drug delivery systems that…”
    Get full text
    Journal Article
  6. 6

    Immunotherapy for glioblastoma: the promise of combination strategies by Bausart, Mathilde, Préat, Véronique, Malfanti, Alessio

    “…Glioblastoma (GBM) treatment has remained almost unchanged for more than 20 years. The current standard of care involves surgical resection (if possible)…”
    Get full text
    Journal Article
  7. 7

    Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems by Xu, Yining, Shrestha, Neha, Préat, Véronique, Beloqui, Ana

    Published in Journal of controlled release (10-06-2020)
    “…Oral drug administration is one of the most preferred and simplest routes among both patients and formulation scientists. Nevertheless, orally delivery of some…”
    Get full text
    Journal Article
  8. 8

    Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment by Ganipineni, Lakshmi Pallavi, Danhier, Fabienne, Préat, Véronique

    Published in Journal of controlled release (10-07-2018)
    “…Glioblastoma (GBM) is one of the most aggressive and deadliest central nervous system tumors, and the current standard treatment is surgery followed by…”
    Get full text
    Journal Article
  9. 9

    RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis by Danhier, Fabienne, Le Breton, Aude, Préat, Véronique

    Published in Molecular pharmaceutics (05-11-2012)
    “…The integrin αvβ3 plays an important role in angiogenesis. It is expressed on tumoral endothelial cells as well as on some tumor cells. RGD peptides are…”
    Get full text
    Journal Article
  10. 10

    An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers by Xu, Yining, Shrestha, Neha, Préat, Véronique, Beloqui, Ana

    Published in Advanced drug delivery reviews (01-08-2021)
    “…[Display omitted] •Oral absorption depends on drug, formulation and gastrointestinal tract.•Different preclinical models are used to evaluate the intestinal…”
    Get full text
    Journal Article
  11. 11

    Cancer DNA vaccines: current preclinical and clinical developments and future perspectives by Lopes, Alessandra, Vandermeulen, Gaëlle, Préat, Véronique

    “…The recent developments in immuno-oncology have opened an unprecedented avenue for the emergence of vaccine strategies. Therapeutic DNA cancer vaccines are now…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Surface Modification of Lipid-Based Nanoparticles by Xu, Yining, Fourniols, Thibaut, Labrak, Yasmine, Préat, Véronique, Beloqui, Ana, des Rieux, Anne

    Published in ACS nano (24-05-2022)
    “…There is a growing interest in the development of lipid-based nanocarriers for multiple purposes, including the recent increase of these nanocarriers as…”
    Get full text
    Journal Article
  14. 14

    Rationally designed drug delivery systems for the local treatment of resected glioblastoma by Bastiancich, Chiara, Malfanti, Alessio, Préat, Véronique, Rahman, Ruman

    Published in Advanced drug delivery reviews (01-10-2021)
    “…[Display omitted] Glioblastoma (GBM) is a particularly aggressive brain cancer associated with high recurrence and poor prognosis. The standard of care,…”
    Get full text
    Journal Article
  15. 15

    Vitamin E-based nanomedicines for anti-cancer drug delivery by Duhem, Nicolas, Danhier, Fabienne, Préat, Véronique

    Published in Journal of controlled release (28-05-2014)
    “…This review aims to highlight the development of novel vitamin E conjugates for the vectorization of active pharmaceutical ingredients through…”
    Get full text
    Journal Article
  16. 16

    Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier by Beloqui, Ana, des Rieux, Anne, Préat, Véronique

    Published in Advanced drug delivery reviews (15-11-2016)
    “…Unraveling the mechanisms of nanoparticle transport across the intestinal barrier is essential for designing more efficient nanoparticles for oral…”
    Get full text
    Journal Article
  17. 17

    PLGA-based nanoparticles: An overview of biomedical applications by Danhier, Fabienne, Ansorena, Eduardo, Silva, Joana M., Coco, Régis, Le Breton, Aude, Préat, Véronique

    Published in Journal of controlled release (20-07-2012)
    “…Poly(lactic-co-glycolic acid) (PLGA) is one of the most successfully developed biodegradable polymers. Among the different polymers developed to formulate…”
    Get full text
    Journal Article
  18. 18

    Fate of polymeric nanocarriers for oral drug delivery by Plapied, Laurence, Duhem, Nicolas, des Rieux, Anne, Préat, Véronique

    “…This review will focus on two polymeric nanocarriers: nanoparticles and micelles that have been studied for oral drug delivery at preclinical level. Their…”
    Get full text
    Journal Article
  19. 19

    Nanocarrier-based drug combination therapy for glioblastoma by Zhao, Mengnan, van Straten, Demian, Broekman, Marike L D, Préat, Véronique, Schiffelers, Raymond M

    Published in Theranostics (2020)
    “…The current achievements in treating glioblastoma (GBM) patients are not sufficient because many challenges exist, such as tumor heterogeneity, the blood brain…”
    Get full text
    Journal Article Book Review
  20. 20

    Iron oxide-loaded nanotheranostics: Major obstacles to in vivo studies and clinical translation by Schleich, Nathalie, Danhier, Fabienne, Préat, Véronique

    Published in Journal of controlled release (28-01-2015)
    “…A major issue in current cancer therapies is the lack of selectivity, which leads to damage in healthy tissues. Therefore, researchers have focused on numerous…”
    Get full text
    Journal Article